Letter | Published:

Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells

Nature Medicine volume 12, pages 13971402 (2006) | Download Citation



The continuous renewal of human epidermis is sustained by stem cells contained in the epidermal basal layer and in hair follicles1,2. Cultured keratinocyte stem cells, known as holoclones3,4,5,6, generate sheets of epithelium used to restore severe skin, mucosal and corneal defects7,8,9. Mutations in genes encoding the basement membrane component laminin 5 (LAM5) cause junctional epidermolysis bullosa (JEB), a devastating and often fatal skin adhesion disorder10. Epidermal stem cells from an adult patient affected by LAM5-β3–deficient JEB were transduced with a retroviral vector expressing LAMB3 cDNA (encoding LAM5-β3), and used to prepare genetically corrected cultured epidermal grafts. Nine grafts were transplanted onto surgically prepared regions of the patient's legs. Engraftment was complete after 8 d. Synthesis and proper assembly of normal levels of functional LAM5 were observed, together with the development of a firmly adherent epidermis that remained stable for the duration of the follow-up (1 year) in the absence of blisters, infections, inflammation or immune response. Retroviral integration site analysis indicated that the regenerated epidermis is maintained by a defined repertoire of transduced stem cells. These data show that ex vivo gene therapy of JEB is feasible and leads to full functional correction of the disease.

  • Subscribe to Nature Medicine for full access:



Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.


  1. 1.

    Stem cell fate and patterning in mammalian epidermis. Curr. Opin. Genet. Dev. 11, 410–417 (2001).

  2. 2.

    & Stem cells of the skin epithelium. Proc. Natl. Acad. Sci. USA 100 (suppl. 1), 11830–11835 (2003).

  3. 3.

    & Three clonal types of keratinocyte with different capacities for multiplication. Proc. Natl. Acad. Sci. USA 84, 2302–2306 (1987).

  4. 4.

    , & Location of stem cells of human hair follicles by clonal analysis. Cell 76, 1063–1073 (1994).

  5. 5.

    et al. Location and clonal analysis of stem cells and their differentiated progeny in the human ocular surface. J. Cell Biol. 145, 769–782 (1999).

  6. 6.

    , , , & Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell 118, 635–648 (2004).

  7. 7.

    , , , & Permanent coverage of large burn wounds with autologous cultured human epithelium. N. Engl. J. Med. 311, 448–451 (1984).

  8. 8.

    et al. Treatment of posterior hypospadias by the autologous graft of cultured urethral epithelium. N. Engl. J. Med. 323, 527–530 (1990).

  9. 9.

    et al. Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet 349, 990–993 (1997).

  10. 10.

    & Molecular complexity of the cutaneous basement membrane zone. Revelations from the paradigms of epidermolysis bullosa. Exp. Dermatol. 5, 1–11 (1996).

  11. 11.

    et al. Compound heterozygosity for an out-of-frame deletion and a splice site mutation in the LAMB3 gene causes nonlethal junctional epidermolysis bullosa. Biochem. Biophys. Res. Commun. 243, 758–764 (1998).

  12. 12.

    et al. Treatment of “stable” vitiligo by Timedsurgery and transplantation of cultured epidermal autografts. Arch. Dermatol. 136, 1380–1389 (2000).

  13. 13.

    et al. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398, 708–713 (1999).

  14. 14.

    et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398, 714–718 (1999).

  15. 15.

    , , & Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J. Invest. Dermatol. 113, 1099–1105 (1999).

  16. 16.

    et al. p63 identifies keratinocyte stem cells. Proc. Natl. Acad. Sci. USA 98, 3156–3161 (2001).

  17. 17.

    et al. Isoforms of DeltaNp63 and the migration of ocular limbal cells in human corneal regeneration. Proc. Natl. Acad. Sci. USA 102, 9523–9528 (2005).

  18. 18.

    , & Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152, 163–175 (1994).

  19. 19.

    et al. Melanoma cells present a MAGE-3 epitope to CD4+ cytotoxic T cells in association with histocompatibility leukocyte antigen DR11. J. Exp. Med. 189, 871–876 (1999).

  20. 20.

    et al. The control of epidermal stem cells (holoclones) in the treatment of massive full-thickness burns with autologous keratinocytes cultured on fibrin. Transplantation 68, 868–879 (1999).

  21. 21.

    et al. Genome-wide analysis of retroviral DNA integration. Nat. Rev. Microbiol. 3, 848–858 (2005).

  22. 22.

    , & Regeneration of squamous epithelia from stem cells of cultured grafts. Regenerative Med. 1, 45–57 (2006).

  23. 23.

    et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415–419 (2003).

  24. 24.

    et al. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 364, 2181–2187 (2004).

  25. 25.

    et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296, 2410–2413 (2002).

  26. 26.

    et al. Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells. Proc. Natl. Acad. Sci. USA 103, 1457–1462 (2006).

  27. 27.

    et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1–EVI1, PRDM16 or SETBP1. Nat. Med. 12, 401–409 (2006).

  28. 28.

    et al. Corrective transduction of human epidermal stem cells in laminin-5-dependent junctional epidermolysis bullosa. Hum. Gene Ther. 9, 1359–1370 (1998).

  29. 29.

    et al. Clonal analysis of stably transduced human epidermal stem cells in culture. Proc. Natl. Acad. Sci. USA 93, 10371–10376 (1996).

  30. 30.

    et al. Increased levels of spliced RNA account for augmented expression from the MFG retroviral vector in hematopoietic cells. Gene Ther. 3, 37–48 (1996).

Download references


We thank S. Bondanza for the clonal analysis of KEP25 keratinocytes shown in Figure 1b, K. Fleishauer for the HLA genotyping, and C. Rossi and D. Sartori for technical assistance. We also thank H. Green (Harvard Medical School) for providing the 3T3-J2 cells and G. Meneguzzi (Institut National de la Santé et de la Recherche Médicale (INSERM) U 634) for providing the K140 antibody to LAM5-β3 and performing the immunofluorescence shown in Figure 3d. This work was supported by grants from Telethon, AFM-Telethon and the European Commission (VI Framework Program, SKINTHERAPY).

Author information


  1. Department of Biomedical Sciences, University of Modena and Reggio Emilia, Via Campi 287, 41100 Modena, Italy.

    • Fulvio Mavilio
    • , Graziella Pellegrini
    • , Francesca Di Nunzio
    • , Alessandra Recchia
    • , Giulietta Maruggi
    •  & Michele De Luca
  2. Epithelial Stem Cell Research Center, Veneto Eye Bank Foundation, H. SS Giovanni and Paolo, Castello 6777, 30100 Venice, Italy.

    • Graziella Pellegrini
    • , Stefano Ferrari
    • , Enzo Di Iorio
    •  & Michele De Luca
  3. Istituto Scientifico H. San Raffaele-Telethon Institute for Gene Therapy (HSR-TIGET) and Vita-Salute University Istituto Scientifico H. San Raffaele, Via Olgettina 58, 20132 Milano, Italy.

    • Giuliana Ferrari
  4. Cancer Immunotherapy and Gene Therapy Program, Istituto Scientifico H. San Raffaele, Via Olgettina 58, 20132 Milano, Italy.

    • Elena Provasi
    •  & Chiara Bonini
  5. Division of Plastic Surgery, H. San Martino, Largo Rosanna Benzi 10, 16132 Genova, Italy.

    • Sergio Capurro
  6. Department of Internal Medicine, University of Modena and Reggio Emilia, Via del Pozzo 71, 41100 Modena, Italy.

    • Andrea Conti
    • , Cristina Magnoni
    •  & Alberto Giannetti


  1. Search for Fulvio Mavilio in:

  2. Search for Graziella Pellegrini in:

  3. Search for Stefano Ferrari in:

  4. Search for Francesca Di Nunzio in:

  5. Search for Enzo Di Iorio in:

  6. Search for Alessandra Recchia in:

  7. Search for Giulietta Maruggi in:

  8. Search for Giuliana Ferrari in:

  9. Search for Elena Provasi in:

  10. Search for Chiara Bonini in:

  11. Search for Sergio Capurro in:

  12. Search for Andrea Conti in:

  13. Search for Cristina Magnoni in:

  14. Search for Alberto Giannetti in:

  15. Search for Michele De Luca in:


F.M., G.P. and M.D.L. designed and directed the study. G.P carried out the clonal analysis, transduced the patient's cells and prepared the skin implants. S.F, F.D.N., E.D.I. and G.M. carried out the hystological and molecular follow-up, G.F. and F.M. constructed the retroviral vectors and the packaging cell line, E.P. and C.B. performed the immunological analysis, S.C., A.C., C.M. and A.G. carried out the transplantation and were responsible for the clinical management of the patient.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Michele De Luca.

Supplementary information

PDF files

  1. 1.

    Supplementary Fig. 1

    Regeneration of a genetically corrected epidermis.

  2. 2.

    Supplementary Fig. 2

    Integration site analysis in cultured keratinocytes.

  3. 3.

    Supplementary Table 1

    Complete list of retroviral integration sites in skin biopsies 1 and 4 months after transplantation

  4. 4.

    Supplementary Table 2

    Analysis of retroviral integration sites in skin biopsies

  5. 5.

    Supplementary Methods

About this article

Publication history






Rights and permissions

To obtain permission to re-use content from this article visit RightsLink.